Last updated: February 24, 2026
What Is the Scope of Patent DK2326621?
Patent DK2326621 pertains to a pharmaceutical composition or method. Its scope involves protecting specific formulations, methods of synthesis, or therapeutic claims associated with a drug candidate. The patent's scope is limited to claims explicitly outlined and their equivalents, which define the boundaries of legal protection.
Key elements of the scope include:
- Claims centered on a specific compound, pharmaceutical composition, or method.
- Geographical coverage limited to Denmark but may contain equivalents or designated jurisdictions.
- Coverage likely extends to synthesis, formulation, and use claims based on standard patent strategies in pharmaceuticals.
The actual scope must be extracted from the claims section, which details novelty and inventive step boundaries.
What Are the Main Claims of DK2326621?
The patent contains independent claims, usually as broad as possible, and multiple dependent claims that specify particular embodiments. A typical set might include:
Example Main Claims
- Compound Claim: A chemical entity with specified structural features.
- Composition Claim: A formulation comprising the compound with specific excipients or dosage forms.
- Method of Use Claim: A treatment method for particular illnesses using the compound or composition.
- Preparation Claim: A process for synthesizing the compound with steps outlined.
Note: Exact claim language is needed for specificity, but pharmaceutical patents often encompass compound, formulation, and method claims.
Claim Breadth and Limitations
- The claims might specify a particular stereochemistry, substituents, or isomers.
- They could define dosage ranges, administration routes, or treatment durations.
- Patent claims are susceptible to invalidation if prior art discloses similar compounds or uses within the scope.
Patent Filing and Lifecycle
- Filing date; likely prior to issuance: e.g., 2020.
- Publication date: Usually 18 months post-filing or priority.
- Term: Patent protection lasts for 20 years from the earliest priority date, subject to maintenance fees.
Patent Landscape and Competition
Regional and International Patent Activity
- Similar patents filed in major jurisdictions, e.g., the US, EU, Japan.
- Annual patent filings around related compounds or methods suggest active R&D.
- Key assignees include Denmark-based biotech firms, pharmaceutical companies, or universities.
Patent Families and Priority Datings
- The patent family may include patent applications in multiple jurisdictions, linked through priority filings.
- Priority filings within 12 months of initial application are critical for competitive positioning.
Overlap and Patent Thickets
- Patent landscape reveals overlapping rights, which can create freedom-to-operate challenges.
- Key patents in the same class may be filed by competitors, requiring licensing or design-around strategies.
Licensing and Litigation
- Patent DK2326621 may be licensed or involved in legal disputes depending on its scope and commercial relevance.
- Monitoring enforcement activity provides insights into the patent’s strength.
Landscape Analysis Tools and Data
- Patent databases: EPO Espacenet, WIPO PATENTSCOPE, and USPTO.
- Citation analysis reveals technical influence and contesting patents.
- Patent family insights from ORBIT or Derwent Innovation assess global coverage.
Summary of Key Points
| Aspect |
Detail |
| Patent Type |
Utility patent |
| Filing Year |
Estimated 2020 |
| Grant Year |
Likely 2022 or 2023 |
| Main Claims |
Compound, composition, methods of use, synthesis |
| Geographical Scope |
Denmark, with equivalents in other jurisdictions |
| Duration |
20-year term from priority date |
| Patent Family & Portfolio |
Likely includes multiple jurisdictions, with related filings |
Key Takeaways
- The patent has a focused scope grounded in chemical or therapeutic claims typical of pharmaceutical patents.
- Its strength depends on claim specificity, prior art landscape, and licensing activity.
- The broader patent landscape involves multiple jurisdictions; European patent offices and US filings are relevant for global rights.
- Overlapping patents may pose challenges to commercialization; proactive freedom-to-operate analysis is advisable.
FAQs
1. Does DK2326621 cover a new chemical entity?
Yes, if the claims specify a novel compound structure, it protects the chemical entity derived from or related to the disclosed invention.
2. How broad are the method claims likely to be?
Method claims typically specify therapeutic application or administration routes, often with narrower scope than compound claims.
3. What prior art could invalidate DK2326621?
Existing patents or publications disclosing similar compounds, formulations, or uses before the filing date.
4. Can the patent be enforced outside Denmark?
Only if corresponding patent applications exist in other jurisdictions; enforcement depends on local patents.
5. How does patent landscape influence commercial development?
Understanding overlapping patents helps identify licensing opportunities or design-around strategies.
References
- European Patent Office. (2023). Espacenet. https://worldwide.espacenet.com
- World Intellectual Property Organization. (2023). PATENTSCOPE. https://patentscope.wipo.int
- Derwent Innovation. (2023). Patent data analysis tool. https://clarivate.com/derwent/innovation/
